Study of TQB3201 tablets for advanced prostate cancer
This trial tests an experimental tablet called TQB3201 for men with advanced prostate cancer that has spread and is no longer responding to standard hormone therapies. The study aims to find the right dose and see how well the drug works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced prostate cancer that has spread to other parts of the body.
- You have tried at least one newer hormone therapy and your cancer got worse.
- Your blood testosterone level is very low (below 50 ng/dL) at screening.
- You are generally able to care for yourself (ECOG performance status 0 or 1).
- Your blood counts and organ function meet minimum safety levels.
- You are willing to provide a tumor sample for genetic testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests a new oral drug, GT-220F, for men whose prostate cancer has spread and no longer responds to hormone therapy. It may be especially for patients whose cancer has specific genetic changes in the PTEN or PIK3CB genes.
This trial tests a new drug, TQB2922, for people with advanced cancers that have not responded to standard treatments. The goal is to see if it is safe and how it affects the cancer.
This trial tests an experimental tablet called TQB3217 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and helps shrink or control the tumor.
This trial tests an experimental drug called TQB3205 for people with advanced solid tumors that have not responded to other treatments. The study will check if the drug is safe and how it affects the tumors.
This trial tests an experimental oral tablet (TQB3117) for people with advanced cancer that has not responded to other treatments. The goal is to find the best dose and see if it is safe.
This trial tests a new drug called TQB3142 in people with advanced cancers that have not responded to standard treatments. The goal is to find a safe dose and see how the drug works in the body.
Hear when a new Metastatic Castration-resistant Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.